4Wysocki AB, Staiano-Coico L, Grinnell F. Wound Fluid from chronic Leg Ulcers Contains Elevated Levels of Metalloproteinases MMP-2 and MMP-9 [J].J Invest Dermatol, 1993,101:64-68.
5Bullen EC, Longaker MT, Updike DL, et al. Tissue Inhibitor of Metalloproteinases-1 Is Decreased and Activated Gelatinases Are Increased in chronic Wounds [J].J Invest Dermatol, 1995,104:236-240.
6Sato H,Takino T,Okada Y,et al.A matrix metalloproteinase expressed on the surface of invasive tumour cells[J].Nature, 1994,370(6484):61-65.
7Nwomeh BC, Liang HX, Diegelmann RF, et al. Dynamics of the matrix metalloproteinases MMP-1 and MMP-8 in acute open human dermal wounds [J].Wound Repair Regen, 1998, 6(2):127-134.
8Edwards DR, Beandry PP, Laing TD, et al. The roles of tissue inhibitors of metalloproteinases in tissue remodeling and cell growth[J].Int J of Obesity, 1996,S9-S15,20 Suppl.
9Vaalamo M, Leivo T, Saarialho-kere U. Differential expression of tissue inhibitors of metalloproteinases(TIMP-1, 2 , 3 , and -4) in normal and aberrant wound healing [J]. Hum Pathol,1999,30(7): 795 -802.
1Deva Ak, Buekland GH, Fisber E, et al. Topical negative pressure in wound management. Med J Aust,2000,173:128-131.
2Argenta LC, Morykmas MJ. A new method for wound control and treatment : clinical experience. Ann Plast Surg, 1997,38 : 563-577.
3Wysocki AB, Staiano-coico L, Grinnell F. Wound Fluid from chronic Leg ulcers contains elevated levels of MMP-2 and MMP-9. J Invest Dermatol,1993.101:64-68.
4Vaalamo M, Mattila L, Johansson N, et al. Distinct population of stromal cells express MMP-13 and MMP-1 in chronic ulcers but not in normally healing wounds. J Invest Dermatol, 1997,109:96-101.
5Stricklin GP, Liol ,Jancic V, et al. Localization of mRNAs representing collagenase and TIMP in sections of healing human bum wounds. Am J Pathol, 1993,143 : 1657-1666.
6Knauper V, Lopez-Otin C, Smith B, et al. Biochemical characterization of human collagenase-3. J Biol Chem, 1996,271 : 1544-1550.
7Vaalamo M, Leivo T, Saarialho-Rere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4) in normal and aberrant wound healing. Hum Pathol, 1999,30 : 795-802.
8Deva AK, Buckland GH, Fisher E, et al. Topical negative pressure in wound management[J]. Med J Aust, 2000, 173(3): 128.
9Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience[J]. Ann Plast Surg, 1997, 38(6): 563.
10Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9[J]. J Invest Dermatol, 1993, 101(1): 64.
4Xie Lu, Chen Meng-hua, Li Jing, et al. Antithrombotic effect of a polysaccharide fraction from Laminaria japonica from the south China sea[J]. Phytotherapy Res, 2011, 25 (9) :1362.
5Ichihashi M, Ahmed N U, Budiyanto A, et al. Prevention effect of antioxidant on ultraviolet-induced skin cancer in mice [ J ]. J Dermatological Sci ,2000,23 ( 1 ) : $45.
6Wlaschek M, Tantcheva-Poor I, Naderi L, et al. Solar UV irra- diation and dermal photoaging [ J ]. J Photochem Photobiol B,2001, 63(1/3) : 41.
7Visse R, Naqase H. Matrix metalloproteinases and tissue inhibi- tors of metalloproteinases: structure, function, and biochemistry. [J]. Circ Res, 2003, 92(8) : S27.
8Ho J H, Su Y, Chen K H, et al. Protection of thymosin beta-4 on corneal endothelial cells from UVB-induced apoptosis[ J]. Chin J Physial, 2010, 53(3):190.
9Sebastian S, Muller W E, Eckert G P. Tocotrienols: constitu- tional effects in aging and disease[J]. J Nutr, 2005, 135(2) : 151.
